Keyphrases
Antisynthetase Syndrome
14%
Autoantibodies
30%
Cancer Risk
5%
Clinical Features
10%
Clinical Trials
5%
Creatine Kinase
6%
Dermatomyositis
49%
Disease Activity
6%
Idiopathic Inflammatory Myopathies
93%
Idiopathic Inflammatory Myositis
5%
Inclusion Body Myositis
15%
Interstitial Lung Disease
19%
Lupus
6%
Magnetic Resonance Imaging
5%
Muscle Biopsy
10%
Muscle Disease
5%
Muscle Weakness
5%
Musculoskeletal Disorders
5%
Myopathy
8%
Myositis
67%
Myositis Autoantibody
10%
OMERACT
15%
Pain Interference
7%
Patient-reported Outcomes
9%
Patient-Reported Outcomes Measurement Information System (PROMIS)
11%
Physical Function
6%
Polymyositis
11%
Reductase
10%
Rheumatic Diseases
8%
Rheumatologists
5%
Statin-induced Myopathy
6%
Statins
19%
Medicine and Dentistry
Antisynthetase Syndrome
12%
Autoantibodies
19%
Biopsy
5%
Clinical Trial
8%
COVID-19
5%
Dermatomyositis
45%
Disease
29%
Inclusion Body Myositis
10%
Interstitial Lung Disease
24%
Magnetic Resonance Imaging
6%
Malignant Neoplasm
6%
Muscle Biopsy
5%
Muscle Disease
5%
Myopathy
22%
Myositis
100%
Oxidoreductase
5%
Patient-Reported Outcome
13%
Polymyositis
14%
Prevalence
9%
Rheumatic Disease
6%
Rheumatology
13%
Symptom
6%
Immunology and Microbiology
Antisynthetase Syndrome
12%
Autoantibodies
51%
Autoantigen
8%
Coenzyme
5%
Dermatomyositis
56%
Inclusion Body Myositis
9%
Monospecific Antibody
7%
Myositis
84%
Polymyositis
15%
Prevalence
5%
